We previously reported a vital relationship between LAT1 and chemosensitivity in pancreatic cancer, indicating that high expression of tumoral LAT1 in pancreatic cancer patients treated with adjuvant chemotherapy was associated with shorter survival, compared to cases with low LAT1 expression. Here, SLC7A5 is linked to familial pancreatic carcinoma.